Skip to content
GTMedTech Logo
Menu
  • GammaTile Therapy
    • Elevating Outcomes
    • Advancing Safety
    • How It Works
  • Clinical Resources
  • GammaTile Centers
  • Recruiting Trials
  • News
  • Events
  • Contact

Tag: GBM Clinical Trial

PharmaNewsIntelligence
News Articles

Bridging Surgical Treatment and Chemoradiation for Glioblastoma Patients

GT Medical announced the first participant enrolled in the GammaTile Enhanced Stupp ALTernative (GESTALT) trial. While this trial is still in its infancy, if the results are favorable, it may influence protocols for treating glioblastomas (GBMs) and bridge the gap between surgery and chemoradiation.

GESTALT Clinical Trial
Press Releases

GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile® Therapy for Newly Diagnosed Glioblastoma Brain Tumors

Enrolling Newly Diagnosed Patients with Glioblastoma in the GESTALT Clinical Trial

GTMedTech Logo White Text

IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS

  • GammaTile Therapy
  • Clinical Resources
  • GammaTile Centers
  • News
  • Events
  • About Us
  • Contact
  • Ordering
  • Returns

©2023 GT Medical Technologies, Inc. | All rights reserved | Instructions for Use | Privacy Policy | Terms of Use